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outcomes of an inflammatory bowel disease (IBD) 
transition cohort and their perspectives.
METHODS: Patients with IBD, aged > 18 years, who 
had moved from paediatric to adult care within 10 
years were identified through IBD databases at three 
tertiary hospitals. Participants were surveyed regarding 
demographic and disease specific data and their 
perspectives on the transition process. Survey response 
data were compared to contemporaneously recorded 
information in paediatric service case notes. Data 
were compared to a similar age cohort who had never 
received paediatric IBD care and therefore who had not 
undergone a transition process. 
RESULTS: There were 81 returned surveys from 46 
transition and 35 non-transition patients. No statistically 
significant differences were found in disease burden, 
disease outcomes or adult roles and responsibilities 
between cohorts. Despite a high prevalence of mood 
disturbance (35%), there was a very low usage (5%) 
of psychological services in both cohorts. In the 
transition cohort, knowledge of their transition plan was 
reported by only 25/46 patients and the majority (54%) 
felt they were not strongly prepared. A high rate (78%) 
of discussion about work/study plans was recorded 
prior to transition, but a near complete absence of 
discussion regarding sex (8%), and other adult issues 
was recorded. Both cohorts agreed that their preferred 
method of future transition practices (of the options 
offered) was a shared clinic appointment with all key 
stakeholders. 
CONCLUSION: Transition did not appear to adversely 
affect disease or psychosocial outcomes. Current 
transition care processes could be optimised, with 
better psychosocial preparation and agreed transition 
plans.  
Key words: Transition care; Crohn’s disease; Ulcerative 
colitis; Chronic illness; Inflammatory bowel disease; 
Patient perspectives; Disease outcomes
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Core tip: Limited data exists regarding psychosocial 
and disease outcomes for inflammatory bowel disease 
patients following transition from paediatric to adult 
care and their perspectives on the process. Our 
study obtained this data through questionnaires and 
compared it to a matched cohort to see if the transition 
process itself influenced outcomes. We found that 
transition programs did not appear to adversely affect 
disease or psychosocial outcomes; however, patients 
have poor knowledge of their transition plan many are 
not strongly prepared. Current transition care practices 
could be optimised and this data contributes to a 
foundation on which future transition practices can be 
designed.
Bennett AL, Moore D, Bampton PA, Bryant RV, Andrews 
JM. Outcomes and patients’ perspectives of transition from 
paediatric to adult care in inflammatory bowel disease. World J 
Gastroenterol 2016; 22(8): 2611-2620  Available from: URL: 
http://www.wjgnet.com/1007-9327/full/v22/i8/2611.htm  DOI: 
http://dx.doi.org/10.3748/wjg.v22.i8.2611
INTRODUCTION
In adolescents with chronic diseases, movement 
from paediatric to adult services is inevitable and is 
increasingly recognised as an essential element of 
holistic care[1-3]. A successful transition in young people 
with chronic conditions differs from simple handover of 
care and should aim to maximise the young person’s 
quality of life[4], with the ultimate goal of facilitating the 
development of successful self-management[5]. 
The topic of transition care has received significant 
attention in the literature[6-9] with considerable debate 
around the most effective way to achieve a smooth 
transition. A general consensus exists however; that 
whatever solution is adopted it should encompass 
a comprehensive programme that reflects and 
encourages the patient’s physical, psychological and 
social development, rather than merely providing 
a physical transfer from paediatric to adult care[10]. 
Implementation of an effective transition program 
has been shown to improve patient health and life 
outcomes in patients with liver transplant[11], diabetes 
mellitus[12] and juvenile arthritis[13] and facilitate self-
reliance[14]. Conversely, if done poorly, adverse effects 
on health[15-17] and health service use[12] in other 
diseases have been reported. There is currently only 
extremely scant outcome data in inflammatory bowel 
disease (IBD).
In Australia, transition practises for IBD are highly 
variable and often involve a physical transfer of the 
patient rather than a coordinated, comprehensive and 
supportive process. This is despite a recent survey of 
adult and paediatric gastroenterologists, reporting that 
this is important[18]. 
Previous IBD transition care literature has high-
lighted multiple barriers to effective transition, with 
several studies obtaining perspectives from paediatric 
and adult gastroenterologists’ and IBD nurses[18-21]. 
From this growing body of literature practical recom-
mendations for transitioning IBD patients have been 
promulgated[22,23]. However, as yet, these proposals 
lack actual outcome data and have omitted patient 
perspectives. Thus it is not yet clear whether these 
recommendations would improve health outcomes. 
Therefore outcome and patient perspective data are 
needed to critically appraise current practices and 
inform the development of interventions intended to 
improve transition outcomes.
The aims of this study were to thus to present such 
factual data and specifically to describe the disease 
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and psychosocial outcomes and personal perspectives 
of a cohort of young adults with IBD who had recently 
moved from paediatric to adult care (transition cohort). 
The outcomes of this group are also compared to a 
cohort of patients with IBD with similar demographics 
and disease duration whose care had been solely in 
the adult realm (non-transition cohort). 
MATERIALS AND METHODS
This cross-sectional study was conducted in three 
parts. Firstly, a cohort of IBD patients diagnosed in 
paediatric services who had moved to adult care was 
identified and surveyed. Secondly, the case records 
of these transition patients were examined to verify 
their histories and to review clinician recorded data on 
transition plans and doctor-patient discussions. Finally, 
a non-transition cohort of young adults with IBD was 
surveyed for comparison.
Transition cohort identification and survey 
In 2013 an IBD database established and maintained 
at the sole public paediatric gastroenterology service in 
South Australia (SA), Women’s and Children’s Hospital 
(WCH), was interrogated to identify people with IBD 
who had turned 18 (mandatory timing of transfer of 
care to adult services) since 2003. Patients diagnosed 
prior to age 18 on the Royal Adelaide Hospital (RAH) 
and Flinders Medical Centre (FMC) IBD databases were 
also identified. Potential participants were invited to 
participate by completing the questionnaire by return 
mail. The questionnaire (Appendix 1) included items 
relating to demographics, disease specific quantitative 
data, patient perspectives regarding their personal 
transition experience and perceived barriers.
During this period in SA, transition of adolescent 
IBD patients to adult healthcare services occurred 
via a letter of referral and if appropriate, telephone 
handover. Only since 2013, has IBD and hospital 
information been sent to the patient and a telephone 
introductory call by an adult IBD service nurse made.
Transition cohort medical records review
In this transition cohort, survey response data were 
compared to contemporaneously recorded information 
in paediatric service case notes. Data regarding the 
planned transition process to adult care, availability 
of choice of location of adult care, timing of transition, 
psychosocial discussions during the transition period 
and disease characteristics at diagnosis were reviewed. 
Medication recommendations, current medication use, 
disease complications and surgery following transition 
to adult care were not reviewed nor confirmed in 
medical records.
Non-transition cohort identification and survey 
A comparative cohort who had not undergone 
transition to adult care was investigated to see whether 
the transition process itself might have influenced 
physical/disease and psychosocial outcomes. This 
cohort was chosen out of a convenience sample of 
young patients diagnosed before 18, but never cared 
for in a paediatric setting. This results from the fact 
that in SA, from age 14, parents have a choice as to 
who (paediatric or adult specialist) cares for their child. 
IBD databases at the RAH and FMC were interrogated 
to derive a cohort which matched (as closely as 
possible) the original transition group cohort for age, 
gender, diagnosis and disease duration. Potential 
participants were invited to participate by completing 
the same questionnaire as the transition cohort with 
exemption of the section relating to personal transition 
experiences. Given that patients in this cohort did not 
undergo the transition process, medical records for this 
group were not reviewed. 
Questionnaires were posted out accompanied 
by a letter of invitation, information sheet, consent 
form and opt-out form. Both the transition and non-
transition cohorts had reminder letters at 2 wk and 
2 mo except for “return to senders” and opt-out 
candidates. All completed surveys were de-identified.
Ethics, consent and permission
The study was approved by the Human Research 
Ethics Committees of the WCH, RAH and FMC. All 
participating patients completed a consent form.
RESULTS
Survey response
Two hundred and twenty three transition patients who 
appeared to have received paediatric IBD care were 
criteria invited to participate. Twenty-three patients 
were uncontactable (post marked “return-to-sender”), 
49 completed surveys and 8 opted out requesting 
no further contact (response rate 49/200 = 24.5%). 
Three of the respondents were subsequently found to 
have received all care in the adult setting and were 
re-allocated to the non-transition cohort, leaving 
46 transition respondents. Of 127 non-transition 
patients invited, 32 completed surveys, 7 opted-out 
and 6 “return-to-senders” were received (response 
rate 32/121 = 26%). The 3 surveys earlier excluded 
from the transition cohort were included in the non-
transition cohort, resulting in 35 respondents (Figure 
1). Not all respondents answered all questions. Data 
are presented as a percentage of those answering 
each item. The response rate did not differ between 
transition and non-transition cohorts (24.5% vs 26%, 
P = 0.69), and non-responders did not differ from 
responders in either cohort in terms of age, gender 
or postcode (as a proxy measure of socioeconomic 
status).
Transition and non-transition cohort characteristics
Amongst transition respondents (n = 46), 31 (67%) 
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patients]. Among transition patients reviewed 15% 
were reviewed 3 monthly or more often, 60% 6 
monthly and 25% annually. This compared with 38%, 
48% and 14% respectively in the non-transition group. 
Twelve out of 22 (55%) transition patients, all of whom 
were public patients, reported contacting their IBD 
nurse as an option if a problem arose and 12 public 
patients felt adequately supported. Of note, these 
were not entirely the same 12 who reported contacting 
the IBD nurses. This compared with approximately the 
same proportion [12/29 (41%)] non-transition patients 
contacting their IBD nurse yet almost all [30/31 (97%)] 
feeling adequately supported. 
Utilisation of members of other the multi-disciplinary 
team was generally low in both cohorts, except for 
their general practitioners (Table 3). The percentage of 
physical, psychological and social side effects relating 
to IBD is outlined in Table 3. The most frequent patient-
reported symptoms listed in descending order of 
frequency included; fatigue, weight loss and diarrhoea; 
mood disturbance and reduced social interactions and 
interruptions to work/school. 
Social and occupational outcomes of transition
No significant differences were seen in the rate of 
achievement of adult roles and responsibilities (marital 
status, education level and employment) between 
patients who transitioned compared to non-transition 
patients (Table 3). 
Transition experience and perceptions
Details regarding personal transition experience are 
outlined in Table 4. Thirty seven (of 46) transition 
patient medical records were available for review to 
had Crohn’s disease (CD), 14 (30%) had ulcerative 
colitis (UC) and one (2%) had IBD-Unclassified. 
Compared to case notes data, correct knowledge 
of disease was found in 100% of patients, however, 
correct knowledge of disease extent was found in only 
18 of 31 patients (58%) with CD and 8/14 (57%) with 
UC. In the non-transition cohort (n = 35), 22 (63%) 
had CD and 13 (37%) had UC. Correct knowledge of 
disease extent was not assessed as case notes for this 
cohort were not reviewed. Cohorts were matched for 
age (P = 0.26) and gender (P = 0.51), but a highly 
statistically significant difference was found between 
cohorts for disease duration (P < 0.000005). No 
significant differences were found between cohorts for 
location of residence or socio-economic status based 
upon post-code. Demographic details for both cohorts 
are outlined in Tables 1 and 2. 
IBD outcomes of transition
No significant difference was found between cohorts 
for occurrence of IBD complications (defined as 
perforation, bowel obstruction or stricture), perianal 
disease, surgery or hospitalisation since diagnosis 
(Table 3).
Similar rates of self-reported medication use for 
most classes of drugs, non-compliance and side effects 
were found in both cohorts (Table 3). Self-reported 
medication recommendations compared to actual 
use was not confirmed given the retrospective nature 
of the study and the lack of a universal prescription 
tracking database.
The majority of respondents were regularly 
reviewed by a gastroenterologist [42/46 (91%), 
transition patients and 30/35 (86%), non-transition 
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223 distributed to 
transition patients
200 with correct 
address
57 replies
49 completed surveys
46 transition surveys
23 RTS
8 opt-outs
3 non-transition
123 distributed to Non-
transition patients
121 with correct 
address
39 replies
32 completed surveys
36 non-transition 
Surveys
6 RTS
7 opt-outs
Figure 1  Recruitment and patient flow. 
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compare with self-reported plans. In the majority 
(29/37, 78%) of case notes reviewed, there was 
evidence of discussion regarding future study/
employment; however, documentation of any sexual 
or psychological discussions was found in only 3 and 7 
patients’ files respectively.
Positive feedback regarding what was done well 
at the time of transition was given by 24 patients 
(52%) and predominantly centred on provision of 
information and communication. Conversely, when 
asked what was done poorly at the time of transition 
10/26 (38%) reported ‘Nothing’ and 3 (12%) reported 
“the handover”. The majority of respondents (37/44, 
84%) were currently continuing with the same adult 
gastroenterologist as initially directed to after transition 
with no difference observed between those directed to 
either the public or private medical setting. 
The majority (44/46, 96%) of the transition cohort 
felt that a structured transition plan was important. 
Non-transition patients also endorsed this statement 
(32/35, 91%). The transition cohort identified 
the task of establishing a new relationship with a 
practitioner; lack of communication and patients’ own 
lack of understanding of their disease as potential 
barriers to successful transition. Similar responses 
were proposed by the non-transition group. Aspects 
suggested by respondents as ways of improving the 
transition process are outline in Table 4. The majority 
of transition respondents thought that the timing of 
transition should be “age 18 years” compared with 
the non-transition cohort who nominated “patient 
readiness”. If timing of transition were to be solely 
based upon age, the transition group identified 
“age 17-18” whereas the non-transition group said 
“depended”. When respondents were asked if the 
timing of transition should be different for males and 
females, both cohorts replied that it would depend on 
the scenario. Both cohorts agreed that their preferred 
method of future transition practices (of the options 
offered) was that “at the time of transfer there is a 
single clinic appointment attended by the patient, 
caregiver, nurse coordinator, paediatric and adult 
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Table 1  Demographic detail for inflammatory bowel disease patient  n  (%)
IBD transition patients (n  = 46) IBD non-transition patients (n  = 35) P  value
Type of IBD
   Crohn’s disease 31 (67) 22 (63) 0.81
   Ulcerative colitis 14 (30) 13 (37) 0.64
   Indeterminate 1 (2) 0 (0) 1.00
Gender
   Male 24 (52) 13 (37) 0.26
   Female 22 (48) 22 (63) 0.26
Current age (yr)
   18-23 26 (57) 17 (49) 0.51
   23-28 20 (43) 18 (51) 0.51
Mean age at diagnosis (yr) 14 17 < 0.000005
Disease duration (yr)    10.7      5.1 < 0.000005
Current location of care
   Public 22 (52) 21 (70) 0.15
   Private 18 (43)   8 (27) 0.21
   Both 2 (5) 1 (3) 1.00
IBD: Inflammatory bowel disease. 
Table 2  Patient demographics with different ages  n  (%)
As a child Current As a child Current
ASGC classification1 (Postcode based)
   RA1 - Major cities 28 (64) 34 (76) 20 (67) 17 (57)
   RA2 - Inner regional   9 (20)   8 (18)   4 (13)   6 (20)
   RA3 - Outer regional 4 (9) 2 (4) 2 (7)   6 (20)
   RA4 - Remote 3 (7) 0 (0)   3 (10) 1 (3)
   RA5 - Very remote 0 (0) 1 (2) 1 (3) 0 (0)
SEIFA classification (IRSAD)2 (quintiles)
   1      8 (18.5)   3 (7.0)      7 (23.3)      6 (20.0)
   2     9 (21.0)   11 (25.5)      3 (10.0)      4 (13.3)
   3   15 (35.0)   11 (25.5)    10 (33.3)    10 (33.3)
   4     6 (14.0)     8 (19.0)      6 (20.0)      4 (13.3)
   5      5 (11.5)   10 (23.0)      4 (13.3)      6 (20.0)
1Australian Standard Geographical Classification - Remoteness Areas[22]; 2Socio-economic Indexes for Areas. The Index of Relative Socio-economic Advantage 
and Disadvantage[23]. NB: No statistical difference was found between cohorts for ASGC or SEIFA classification. NB: Not all subjects answered every 
question and consequently the denominators for each response are provided.
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Table 3  Inflammatory bowel disease outcomes of transition  n  (%)
gastroenterologist”.  
DISCUSSION
This is the first study to simultaneously describe and 
compare outcome data and patients’ perspectives with 
regard to transition, in a cohort of paediatric onset IBD 
patients who have since moved on to adult care. 
Approximately 25% of IBD patients are diagnosed 
under the age of 16 years[24] with data to suggest that 
onset in this period can have a more active disease 
course than in adults[25]. Our data suggests that 
despite active disease in paediatric years (frequent 
flares and hospital admissions), the cohort appears 
to have better disease control after entering adult 
care. This is represented by an apparent reduction 
in hospital admissions after leaving paediatric care 
with a comparable figure to the non-transition cohort. 
In addition, transition did not appear to significantly 
affect the rate of complications, surgery requirements, 
hospitalisation or perianal disease, which may seem 
surprising given the longer disease duration in the 
transition cohort. 
Medication use was similar with self-reported non-
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Transition cohort Non-transition cohort P  value
Medication (self-reported)
5-aminosalicylic acid 19 (41) 14 (41) 1.00
   Sulfasalazine
   Mesalazine
Immunomodulator 30 (65) 25 (71) 0.63
   Azathioprine/6  27 24
   Mercaptopurine 
   Methotrexate   3   1
Biologic therapy (anti-TNF)   8 (17)   9 (26) 0.42
   Infliximab   6   5
   Adalimumab   2   4
Non-compliance 3 (7) 4 (11) 0.46
Perianal disease   9 (20) 8 (24) 0.79
Complications (Perforation, bowel obstruction, stricture) 12 (26) 5 (14) 0.27
Surgery (Resection +/- stoma, fistula with seton) 15 (33) (9 prior to transition) 10 (29) 0.81
Number of hospital admissions per patient (median)
   During paediatric care 3.2 N/A
   During adult care 1.5 2.1 0.67
Number of flares requiring steroids per patient (median)
   Since transition 0.5 N/A
   During last year 0.5 1 0.31
Extra intestinal manifestations of IBD (Arthropathy/Cutaneous/Ocular/
Hepatobiliary/Metabolic bone disease)1
6 (14) 8 (24) 0.37
IBD symptoms
   Physical 39 (85) 33 (94) 0.29
   Psychological 16 (35) 16 (46) 0.36
   Social 29 (63) 26 (76) 0.23
MDT utilisation
   General Practitioner 34 (74) 25 (69) 0.80
   Psychologist 2 (4) 3 (8) 0.65
   Dietician   9 (20)   7 (19) 1.00
   Colorectal surgeon 12 (26) 11 (31) 0.80
   IBD nurse 11 (24) 19 (25) 0.01
Relationship status
   Single 22 (48) 17 (49) 1.00
   In a relationship 20 (43) 12 (34) 0.49
   Married 4 (9)   6 (17) 0.32
   Divorced 0 (0) 0 (0) 1.00
Education (level completed)
   Primary   43 (100)   35 (100) 1.00
   Secondary 38 (88) 27 (77) 0.23
   Tertiary 19 (41)   5 (14) 0.01
   TAFE (Technical and further education) 8 (17) 12 (34) 0.12
   Apprenticeship/trade 6 (13)   7 (20) 0.54
Employment
   Currently employed 35 (76) 21 (60) 0.15
   Full-time employment 21 (60) 11 (52) 0.59
   Average hours worked/week 29.8 34.2
1Mouth ulcers were omitted. IBD: Inflammatory bowel disease.
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compliance being low in both cohorts (7% transition, 
11% non-transition). This is lower than 35% observed 
by López San Román et al[26] however; it is important 
to highlight that in reality, when objective measures of 
adherence were used, it is found that nearly 50% of 
patients do not take medications as prescribed[27].
The majority of the transition patients in our cohort 
appear to be coping well, as assessed by educational 
activity, employment and partnership rates. These 
findings are similar to the comparison non-transition 
cohort and more reassuringly also to Australian 
Bureau of Statistic population data[28,29] (based upon 
similar age categories). The only other paper to our 
knowledge examining these outcomes in young 
IBD patients found lower rates of further education 
and employment (50%)[30], and thus our data is 
reassuring.
Turunen et al[31] found that the quality of life of the 
patients with paediatric onset of IBD was decreased 
in early adulthood when compared to population-
based controls. Our data supports this notion with 
a significant proportion (35%) reporting mood 
disturbance but despite this, psychological services 
are underutilised, with only 5% of those with mood 
disturbances accessing specific care. Whilst this data 
is comparable to that of the non-transition cohort 
suggesting that the transition process itself may not 
be the sole influence, it is concerning as it represents 
a lost opportunity to optimise their outcomes entering 
adult life. 
Adult providers have identified a lack of medical 
knowledge in young patients with IBD transferred from 
the paediatric clinics[32], which may impair the success 
of transition. Pleasingly, 100% of patients in both 
the reported cohorts were able to correctly indicate 
their diagnosis. However, only 58% of the transition 
cohort correctly reported their extent of disease. This 
ignorance of an important aspect of their disease is in 
keeping with previous data trends[32,33]. It is concerning 
given the potential practical ramifications of preventing 
effective self-assessment and management. Provision 
of written information to adolescents, such as an IBD 
passport[34], may alleviate this knowledge gap. 
A further area of significant concern is the rare 
documentation of any discussion regarding sexuality 
and reproduction on notes review of transitioning 
patients (in 3/34 notes only). Many young people 
are sexually active before age 18[35], and the lack of 
early discussion misses an opportunity to inform them 
accurately about how their IBD and especially any 
immunosuppressant therapy may or may not affect 
sexual function, sexually transmitted infections, fertility 
and pregnancy. This is an area where there is known to 
be poor knowledge amongst patients and primary care 
doctors[36-39], which can be helped by brief education[40]. 
Whilst paediatric gastroenterologists may not feel 
equipped or comfortable to do this, if they do not start 
the discussion in may be left until they are sexually 
active and it may be too late. These issues may have 
been discussed but not documented, highlighting 
the need for a transition checklist so that they are 
indeed addressed perhaps with specific assistance for 
paediatricians who may not be comfortable with these 
discussions.
Currently less than half of transition respondents 
feel that the process they experienced was adequate, 
with 23% not feeling prepared and 42% not feeling part 
of the decision making process. Whilst approximately 
half of respondents recalled knowledge of a “transition 
plan”, medical records indicate that this was docu-
mented in nearly all patients. This suggests that 
although the idea of transition was discussed 1 year 
on average prior to actual transition (recorded in 
notes) it may not be long enough or involve sufficient 
discussion/documentation to prepare/engage the patient. 
Future programs may need to involve distribution of 
written information or use of on-line resources, rather 
than a simple note in the file, as something to look at 
away from the doctor’s office.
Our cohort identified aspects of their transition 
experience that were done well and poorly, pleasingly, 
these were similar to key concepts of successful 
transition highlighted in a recent overview of the 
topic[10], suggesting clinicians have a good idea of how/
where to make changes.
Adolescents with IBD have been highlighted 
as a group where there are significant barriers to 
transition to adult care[7]. The barriers identified by 
patients in our study, in addition to poor patient 
knowledge, concur with results from a small study 
of surveyed IBD patients in Spain[41]. Findings differ 
however, to a medical position paper based upon 
recommendations of the North American Society for 
Pediatric Gastroenterology, Hepatology and Nutrition. 
Barriers discussed related to the reluctance of the 
patient, their family and medical providers for transition 
and the lack of a clear and consistent route to follow 
by medical practitioners[42]. Further survey data 
obtained from the perspectives of adult and paediatric 
gastroenterologists and nurses highlights suboptimal 
training for adult gastroenterologists[43], lack of entities 
2617 February 28, 2016|Volume 22|Issue 8|WJG|www.wjgnet.com
Table 4  Transition experience and perceptions  n  (%)
Age at first discussion of transition (yr)
   Median 18 (Range: 16-18)
   Mean 17
Age at transition (yr)
   Median 18 (Range: 16-19)
   Mean 18 
Knowledge of transition plan by patient 16 (36)
Case note documentation of transition plan 32 (86)
Patient prepared for transition
   Not prepared 10 (23)
   Slightly prepared 15 (34)
   Strongly prepared 19 (43)
Transition felt to be structured 26 (63)
Part of transition decision making process 25 (58)
Patient reported choice of transition plan 1 (3)
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such as resources, and clinician time[20,43], and lack 
of self-advocacy[42] as the main barriers. Perspectives 
on this topic are diverse and vary according to the 
cohort surveyed, with a paucity of viewpoints from 
patient cohorts in published literature. Our study has 
shown that patient perspectives differ to those aired 
by healthcare professionals and are vital, as without 
them we risk designing a system which suits medical 
professionals and not patients. Regardless of the origin, 
barriers identified can potentially lead to sub-optimal 
outcomes, which have been observed in existing chronic 
illness programme descriptions[31]. Being aware of all 
barriers is essential to any proposed system re-design 
to ensure what is done, is practical and acceptable to all 
stakeholders. 
Currently, changes in transition practices are being 
recommended[7,43,44] without knowing what is actually 
happening to this cohort and what their preferences 
are. When specifically asked what they would prefer 
as a transition practice the majority of our transition 
cohort agreed that a period of overlapping care with 
a single clinic appointment attended by the patient, 
caregiver, nurse coordinator, paediatric and adult 
gastroenterologist would be the most appropriate. 
This technique has been shown to be beneficial for 
increasing IBD patients “readiness” for transfer[45], and 
among diabetic patients in improving disease control 
and increasing rates of follow up[2]. 
Despite the uniqueness of the data collected we 
recognise the limitations of our study. The foremost 
is the response rate (about 25%) in both cohorts. 
These response rates are similar for other young adult 
cohorts without incentive[46,47], and whilst one cannot 
regard the data as conclusive, one can certainly draw 
inferences and make suggestions based on this data in 
conjunction with the scant existing literature. Moreover 
the data are likely to be representative as there does 
not appear to be either a strong positive or negative 
responder bias as no difference in SES, age or gender 
was found between responders and non-responders. 
Secondly although the cohorts were matched for 
age and disease, there was a statistically significant 
difference in disease duration, despite rigorous 
attempts to match for this, which may have led to 
differences in disease outcomes. Responders did not 
differ in age, gender or postcode from non-responders 
so this is somewhat reassuring that there is not a 
large source of bias. Whilst these limitations exist we 
feel that our methodology is the most appropriate, 
as we are documenting outcomes of an existing 
process before changing it, so any alterations address 
deficiencies and are in line with patients’ wishes. 
Whilst recent transition practice did not appear to 
adversely affect disease or psychosocial outcomes, 
current processes could be optimised, with better 
psychosocial preparation, greater awareness of mood 
disturbance, more effective provision of psychological 
care and explicitly documented and shared transition 
plans. These new data which include young patients’ 
perspectives are an important missing piece that 
contributes to a foundation on which future transition 
practices can be designed to optimise the process and 
improve outcomes.
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Background
Transitioning of adolescent patients with inflammatory bowel disease (IBD), a 
chronic, lifelong condition, is inevitable and an important aspect of their holistic 
care. Effective transition programs have been shown to improve patient health 
and life outcomes in other chronic diseases and conversely, if done poorly, 
adverse effects on health and health service use have been reported. Whilst 
transition practices are highly variable worldwide, a successful transition 
in young people with chronic conditions should aim to maximise the young 
person’s quality of life, with the ultimate goal of facilitating the development of 
successful self-management. 
Research frontiers
Previous IBD literature has highlighted multiple barriers to effective transition 
with practical recommendations being made. However, these proposals lack 
actual outcome data and patient perspectives and thus it is not yet clear 
whether these recommendations would improve health outcomes. This 
study simultaneously describes and compares outcome data and patients’ 
perspectives with regard to transition and provides important information in a 
field where IBD data is minimal.
Innovations and breakthroughs
This study is the first of its kind to present disease outcome data and patient 
perspectives in an IBD transition cohort. The authors found that whilst recent 
transition practices did not appear to adversely affect disease or psychosocial 
outcomes, current processes could be optimised, with better psychosocial 
preparation, greater awareness of mood disturbance, more effective provision 
of psychological care and explicitly documented and shared transition plans. 
Applications
These new disease and psychosocial outcome data in addition to young 
patients’ perspectives are an important missing piece that contributes to a 
foundation on which future transition practices can be designed to optimise the 
process and improve outcomes.
Terminology
The main concept of transition care is that it should encompass a comprehensive 
programme that reflects and encourages the patient’s physical, psychological 
and social development, rather than merely providing a physical transfer from 
paediatric to adult care.
Peer-review
This is a retrospective study, a survey, on an important aspect in IBD, transition 
care. In this cross-sectional study, the authors provide well documented 
outcomes of transition from paediatric to adult care in a large group of patients 
with IBD.
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